普利制药 (300630.SZ)

今开: 最高: 成交量:

昨收: 最低: 成交额:

+ 收藏

利润表(单季度)(普利制药)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2024年第三季度2024年第二季度2024年第一季度2023年第四季度2023年第三季度2023年第二季度2023年第一季度
上市前/上市后 上市后上市后上市后上市后上市后上市后上市后
报表类型 合并报表合并报表合并报表合并报表合并报表合并报表合并报表
一、营业总收入(元) 187,782,077.49131,134,793.67306,327,292.17681,338,756.53152,793,968.77255,675,662.46214,674,952.82
 营业收入(元) 187,782,077.49131,134,793.67306,327,292.17681,338,756.53152,793,968.77255,675,662.46214,674,952.82
二、营业总成本(元) 265,313,409.29327,166,403.54222,052,785.84531,898,613.25283,265,681.73285,508,495.68200,006,585.05
 营业成本(元) 95,971,173.4781,008,975.1774,208,073.11114,002,924.6284,248,206.5892,108,300.7461,152,705.92
 研发费用(元) 32,405,663.8756,282,859.8954,739,728.5037,831,987.3598,122,072.6970,200,782.4361,517,923.07
 营业税金及附加(元) 2,655,301.973,507,590.10768,350.6411,747,177.431,163,681.862,207,034.822,374,980.84
 销售费用(元) 85,482,794.72131,020,139.0547,803,835.68280,288,168.6552,354,284.8076,181,716.9651,140,496.07
 管理费用(元) 33,177,177.2437,343,797.1135,425,494.5568,250,614.7934,979,583.8138,429,595.2715,061,173.01
 财务费用(元) 15,621,298.0218,003,042.229,107,303.3619,777,740.4112,397,851.996,381,065.468,759,306.14
  其中:利息费用(元) 10,809,716.84--21,219,700.9912,260,028.85--
  其中:利息收入(元) -1,156,947.743,185,693.331,734,804.18572,548.27571,198.91--
 资产减值损失(元) -505,270.23---15,151,519.94---
 信用减值损失(元) 15,198,109.326,782,695.961,153,464.29-39,137,021.91-5,843,866.405,899,929.6110,985,229.00
三、其他经营收益
 加:投资收益(元) 5,072,329.00---137,966.581,405,772.38671,139.282,463,766.47
 其他收益(元) 17,538,876.7316,072,565.863,000,654.5225,612,561.2621,061,443.4927,784,543.539,070,325.65
四、营业利润(元) -40,227,286.98-173,154,330.2788,428,625.14120,626,196.11-113,848,363.493,921,162.4537,187,688.89
 加:营业外收入(元) 220,493.9034,938.6956,531.4129,243,833.6638,706.5782,469.0119,399.77
 减:营业外支出(元) 9,225,583.663,552,921.5228,826.722,257,907.39177,914.4614,865.8682.03
五、利润总额(元) -49,232,376.74-176,672,313.1088,456,329.83147,612,122.38-113,987,571.383,988,765.6037,207,006.63
 减:所得税费用(元) -7,774,709.96-53,169,379.6921,765,847.17155,381,341.22-110,727,347.93-26,568,297.26-29,188,238.34
六、净利润(元) -41,457,666.78-123,502,933.4166,690,482.66-7,769,218.84-3,260,223.4530,557,062.8666,395,244.97
(一)按经营持续性分类
  持续经营净利润(元) -41,457,666.78-123,502,933.4166,690,482.66-7,769,218.84-3,260,223.45--
(二)按所有权归属分类
  归属于母公司股东的净利润(元) -41,457,666.78-123,502,933.4166,690,482.66-7,769,218.84-3,260,223.4530,557,062.8666,395,244.97
 扣除非经常性损益后的净利润(元) -52,497,552.83-136,661,401.2264,267,415.23-365,162,447.39116,215,968.02107,491,634.32128,887,445.84
七、每股收益
 一、基本每股收益(元) -0.09-0.280.15-0.010.06-0.15
 二、稀释每股收益(元) -0.09-0.260.14-0.010.06-0.14
九、综合收益总额(元) -41,457,666.78-123,502,933.4166,690,482.66-7,769,218.84-3,260,223.4530,557,062.8666,395,244.97
 归属于母公司所有者的综合收益总额(元) -41,457,666.78-123,502,933.4166,690,482.66-7,769,218.84-3,260,223.45--
公告日期 2024-10-282024-08-292024-07-052024-07-052023-10-252023-08-252023-04-25
审计意见(境内) 保留意见

前瞻产业研究院